Active Implants Initiates Second Clinical Trial Evaluating NUsurface Meniscus Replacement

By Julie A. Vetalice

Active Implants initiated SUN (Safety Using NUsurface®), a 2nd clinical trial evaluating the investigational meniscus implant.

The single-arm, prospective, open-label, non-randomized observational trial will enroll ~120 patients with persistent knee pain caused by injured or deteriorating meniscus cartilage, at up to 20 U.S. sites.

Sources: Active Implants LLC, ClinicalTrials.gov

This trial joins the VENUS Study (Verification of the Effectiveness of the NUsurface System), which has been underway at 10 sites in the U.S. since 1Q15. Both studies are being conducted to support FDA regulatory approval.

Product Labels: Traditional Soft Tissue Repair

Tags: Trial/Study